Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology103
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer33
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo33
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance32
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond32
Mitochondria, OXPHOS, and Cancer Progression: A Modular View31
Lessons from 3D Reconstruction of Cancer26
Natural and Engineered Cytokines as Cancer Therapeutics21
Allogeneic CAR T Cell Therapy for Cancer21
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity17
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology16
Road Map to Defeat Pancreatic Cancer15
Cancer Cell Polarity and Extrusion14
An Erratic Path Toward Discovery14
Cancer Dependency Map: Past and Present14
Engineering Cancer with Next-Generation Genome Editing Tools14
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies14
0.037811994552612